Health News

Online Tool Identifies Blood Clot Risk
Most individuals have no idea whether they are at risk for a serious blood clot. A new online tool featuring simple questions patients can answer may help identify those in need of preventative treatment.
Addiction Defined
People can be addicted to anything - food, drugs, sex, gambling and more. It's a problem that has affected many, but it's not a behavioral problem like many believe.
Fish Oil May Encourage Brain Health
Fish oil has become a popular health supplement in recent years. It may be with good reason. Fish oil supplements appear to offer benefits for brain health and aging.
Lung Cancer Makes Scents to Dogs
The super sensitive noses of dogs are known to be able to pick up the scent many things. Man's best friend can now do what even advanced medical tests can't do - sniff out early stage lung cancer.
Late-Stage Melanoma Drug Approved
The U.S. Food and Drug Administration has approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
Alcohol Dependence Depends on Metabolism
Alcoholism can happen at any age in life and it seems like men and women react differently to alcohol dependence. A genetic variation may explain the difference.
1 in 10 Children May Have ADHD
Over the last decade, the numbers of American children diagnosed with attention deficit hyperactivity disorder (ADHD) have been increasing, more than 2 percent from just ten years ago.
Social Drinking Keeps Alzheimer's Away
Don't hesitate to lift your glass for a toast. Social drinking can significantly reduce your chance of developing Alzheimer's disease or another form of dementia.
FDA Approves Drug to Treat Two Lymphomas
The U.S. Food and Drug Administration has approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL).
Parkinson's Treatment Gains Traction
Deep brain stimulation is gaining acceptance as a treatment capable of helping Parkinson's disease patients with motor function. However, about half of the patients referred for the treatment aren't good candidates.